*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.
*NOTE: COVID-19 and RSV vaccine recommendations have recently been updated for some populations. This resource will be updated to reflect the CDC’s latest guidance. Because CDC recommendations may impact insurance coverage, you should check with your insurance provider to make sure you’re covered.
Recent changes to recommendations for adult pneumococcal disease and RSV vaccines have created an important opportunity to assess how expanded vaccine recommendations translate into real-world vaccination practices. This webinar highlighted IQVIA data on adult vaccination trends, offering timely evidence of how vaccine recommendations can drive uptake.
Panelists explored the implications of routine, risk-based, and shared clinical decision-making vaccine recommendations for providers, patients, and public health systems. The conversation focused on how clarity in recommendations affects provider confidence and patient access, and what lessons recent ACIP decisions offer for the future of adult immunization policy.
Panelists included:
